Hiroshi Koga, Ayaka Ohzono, Masahiro Tsutsumi, Sakura Maeda, Norito Ishii. IgM Pemphigoid With Anti‐BP180 C‐Terminal Autoantibodies Developing After Pembrolizumab and Enfortumab Vedotin Therapy. // Journal of Dermatology. – 2026. – DOI: 10.1111/1346-8138.70578. – URL: https://onlinelibrary.wiley.com/doi/10.1111/1346-8138.70578?af=R
Hiroshi Koga, Ayaka Ohzono, Masahiro Tsutsumi, Sakura Maeda, & Norito Ishii (2026). IgM Pemphigoid With Anti‐BP180 C‐Terminal Autoantibodies Developing After Pembrolizumab and Enfortumab Vedotin Therapy. Journal of Dermatology. https://doi.org/10.1111/1346-8138.70578
Hiroshi Koga, et al. “IgM Pemphigoid With Anti‐BP180 C‐Terminal Autoantibodies Developing After Pembrolizumab and Enfortumab Vedotin Therapy.” Journal of Dermatology, 2026. doi:10.1111/1346-8138.70578.
@article{Koga2026,
title = {IgM Pemphigoid With Anti‐BP180 C‐Terminal Autoantibodies Developing After Pembrolizumab and Enfortumab Vedotin Therapy},
author = {Koga, Hiroshi and Ohzono, Ayaka and Tsutsumi, Masahiro and Maeda, Sakura and Ishii, Norito},
journal = {Journal of Dermatology},
year = {2026},
doi = {10.1111/1346-8138.70578},
url = {https://onlinelibrary.wiley.com/doi/10.1111/1346-8138.70578?af=R}
}